About N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide
N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide (PubChem CID 6929067) has the molecular formula C15H18ClN4O2+
and a molecular weight of 321.79 g/mol. Its IUPAC name is N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide.
Analyze N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide?
The IUPAC name of N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide (CID 6929067) is N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide.
What is the SMILES notation for N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide?
The canonical SMILES for N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide is Cc1onc(-c2ccccc2Cl)c1NC(=O)N1CC[NH2+]CC1.
What is the InChIKey of N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide?
The InChIKey is OIQRZZVPMANNHP-UHFFFAOYSA-O. The full InChI is InChI=1S/C15H17ClN4O2/c1-10-13(18-15(21)20-8-6-17-7-9-20)14(19-22-10)11-4-2-3-5-12(11)16/h2-5,17H,6-9H2,1H3,(H,18,21)/p+1.
What are the key properties of N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide?
N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide has a molecular weight of 321.79 g/mol, XLogP of 1.71, 2 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]piperazin-4-ium-1-carboxamide is sourced from PubChem (CID 6929067), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).